Europe Immunohistochemistry Market to Grow at a CAGR of 7.1% to reach US$ 1,022.27 million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Immunohistochemistry Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Immunohistochemistry Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Increasing Geriatric Population
5.1.3 Increasing R&D Investments by Biotechnology & Biopharmaceutic mpanie

5.2 Market Opportunities

5.2.1 Development Opportunities in Emerging Countries

5.3 Future Trends

5.3.1 Increasing Acceptance of Automation in Immunohistochemistry

5.4 Impact of Drivers and Restraints

6. Europe Immunohistochemistry Market Regional Analysis

6.1 Europe Immunohistochemistry Market Overview

6.2 Europe Immunohistochemistry Market Revenue 2019-2028 (US$ Million)

6.3 Europe Immunohistochemistry Market Forecast Analysis

7. Europe Immunohistochemistry Market Analysis – by Application

7.1 Diagnostics

7.1.1 Overview
7.1.2 Diagnostics: Europe Immunohistochemistry Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Drug Testing

7.2.1 Overview
7.2.2 Drug Testing: Europe Immunohistochemistry Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Immunohistochemistry Market Analysis – by Product

8.1 Antibodies

8.1.1 Overview
8.1.2 Antibodies: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Reagents

8.3.1 Overview
8.3.2 Reagents: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Kits

8.4.1 Overview
8.4.2 Kits: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Immunohistochemistry Market Analysis – by End User

9.1 Hospitals and Diagnostic Laboratories

9.1.1 Overview
9.1.2 Kits: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Kits: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Immunohistochemistry Market – Europe Analysis

10.1 Europe

10.1.1 Europe Immunohistochemistry Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Immunohistochemistry Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Immunohistochemistry Market Breakdown, by Application
10.1.1.1.2 UK: Europe Immunohistochemistry Market Breakdown, by Product
10.1.1.1.3 UK: Europe Immunohistochemistry Market Breakdown, by End User

10.1.1.2 Germany: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Immunohistochemistry Market Breakdown, by Application
10.1.1.2.2 Germany: Europe Immunohistochemistry Market Breakdown, by Product
10.1.1.2.3 Germany: Europe Immunohistochemistry Market Breakdown, by End User

10.1.1.3 France: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Immunohistochemistry Market Breakdown, by Application
10.1.1.3.2 France: Europe Immunohistochemistry Market Breakdown, by Product
10.1.1.3.3 France: Europe Immunohistochemistry Market Breakdown, by End User

10.1.1.4 Russia: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Immunohistochemistry Market Breakdown, by Application
10.1.1.4.2 Russia: Europe Immunohistochemistry Market Breakdown, by Product
10.1.1.4.3 Russia: Europe Immunohistochemistry Market Breakdown, by End User

10.1.1.5 Italy: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Immunohistochemistry Market Breakdown, by Application
10.1.1.5.2 Italy: Europe Immunohistochemistry Market Breakdown, by Product
10.1.1.5.3 Italy: Europe Immunohistochemistry Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Immunohistochemistry Market Breakdown, by Application
10.1.1.6.2 Rest of Europe: Europe Immunohistochemistry Market Breakdown, by Product
10.1.1.6.3 Rest of Europe: Europe Immunohistochemistry Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Immunohistochemistry Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abcam plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Agilent Technologies, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bio SB

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BIO-RAD LABORATORIES INC.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Cell Signaling Technology, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Danaher

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 F. HOFFMANN-LA ROCHE LTD.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 MERCK KGaA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 PerkinElmer Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 THERMO FISHER SCIENTIFIC INC.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights